Immuno-oncology collaboration to develop innovative new type of cancer drug 18 Apr 2023 Scientists at The Institute of Cancer Research, London, are teaming up with small molecule neoantigen immuno-oncology company NeoPhore to develop new potential cancer drugs. Find out more Show/Hide